Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An inflammatory Signature of Glucose Impairment in Cystic Fibrosis.
Montemari AL, Manco M, Fiocchi AG, Bartoli M, Facchiano F, Tabolacci C, Scatigna M, Ciciriello F, Alghisi F, Montemitro E, Carsetti R, Lucidi V, Fiscarelli EV. Montemari AL, et al. Among authors: fiscarelli ev. J Inflamm Res. 2022 Oct 10;15:5677-5685. doi: 10.2147/JIR.S365772. eCollection 2022. J Inflamm Res. 2022. PMID: 36238762 Free PMC article.
Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.
Iannitti RG, Casagrande A, De Luca A, Cunha C, Sorci G, Riuzzi F, Borghi M, Galosi C, Massi-Benedetti C, Oury TD, Cariani L, Russo M, Porcaro L, Colombo C, Majo F, Lucidi V, Fiscarelli E, Ricciotti G, Lass-Flörl C, Ratclif L, Esposito A, De Benedictis FM, Donato R, Carvalho A, Romani L. Iannitti RG, et al. Am J Respir Crit Care Med. 2013 Dec 1;188(11):1338-50. doi: 10.1164/rccm.201305-0986OC. Am J Respir Crit Care Med. 2013. PMID: 24127697
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.
Iannitti RG, Napolioni V, Oikonomou V, De Luca A, Galosi C, Pariano M, Massi-Benedetti C, Borghi M, Puccetti M, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Cariani L, Russo M, Porcaro L, Ricciotti G, Ellemunter H, Ratclif L, De Benedictis FM, Talesa VN, Dinarello CA, van de Veerdonk FL, Romani L. Iannitti RG, et al. Nat Commun. 2016 Mar 14;7:10791. doi: 10.1038/ncomms10791. Nat Commun. 2016. PMID: 26972847 Free PMC article.
Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G, Paganin P, Lopez L, Vanni C, Dalmastri C, Cantale C, Daddiego L, Perrotta G, Dolce D, Morelli P, Tuccio V, De Alessandri A, Fiscarelli EV, Taccetti G, Lucidi V, Bevivino A, Mengoni A. Bacci G, et al. Among authors: fiscarelli ev. PLoS One. 2016 Jun 29;11(6):e0156807. doi: 10.1371/journal.pone.0156807. eCollection 2016. PLoS One. 2016. PMID: 27355625 Free PMC article.
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.
Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L. Moretti S, et al. Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017. Nat Commun. 2017. PMID: 28090087 Free PMC article.
Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P, Del Chierico F, Russo A, Majo F, Rossitto M, Valerio M, Casadei L, La Storia A, De Filippis F, Rizzo C, Manetti C, Paci P, Ercolini D, Marini F, Fiscarelli EV, Dallapiccola B, Lucidi V, Miccheli A, Putignani L. Vernocchi P, et al. Among authors: fiscarelli ev. PLoS One. 2018 Dec 6;13(12):e0208171. doi: 10.1371/journal.pone.0208171. eCollection 2018. PLoS One. 2018. PMID: 30521551 Free PMC article.
74 results